We are live on ! Find out more
OA

Operose Advisors Portfolio holdings

AUM $517M Turnover 40.26%
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
-6.22%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$10.1M
Cap. Flow
+$20.9M
Cap. Flow %
13.73%
Top 10 Hldgs %
72.51%
Holding
351
New
49
Increased
55
Reduced
24
Closed
8
Avg Time Held
0.6 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.43%
2 Financials 4.35%
3 Technology 3.04%
4 Consumer Discretionary 1.8%
5 Healthcare 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LNT icon
226
Alliant Energy
LNT
$17.6B
$17K 0.01%
320
– –
2021 Q4
3 quarters
MCHP icon
227
Microchip Technology
MCHP
$41B
$17K 0.01%
280
– –
2021 Q4
3 quarters
PLD icon
228
Prologis
PLD
$120B
$17K 0.01%
168
– –
2021 Q4
3 quarters
QCOM icon
229
Qualcomm
QCOM
$189B
$17K 0.01%
150
– –
2021 Q4
3 quarters
CLX icon
230
Clorox
CLX
$10.5B
$16K 0.01%
+123
New +$17.7K
2022 Q3
0 quarters
GPC icon
231
Genuine Parts
GPC
$18.5B
$16K 0.01%
105
– –
2021 Q4
3 quarters
MMM icon
232
3M
MMM
$84.8B
$16K 0.01%
169
-478
-74% -$52.4K
2021 Q4
3 quarters
OEF icon
233
iShares S&P 100 ETF
OEF
$20.5B
$16K 0.01%
100
– –
2021 Q4
3 quarters
TEVA icon
234
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$16K 0.01%
+2,000
New +$17.7K
2022 Q3
0 quarters
BL icon
235
BlackLine
BL
$1.71B
$15K 0.01%
250
– –
2022 Q1
2 quarters
EW icon
236
Edwards Lifesciences
EW
$49.9B
$15K 0.01%
183
– –
2021 Q4
3 quarters
LMT icon
237
Lockheed Martin
LMT
$126B
$15K 0.01%
40
– –
2022 Q1
2 quarters
TMO icon
238
Thermo Fisher Scientific
TMO
$254B
$15K 0.01%
30
– –
2022 Q1
2 quarters
DOW icon
239
Dow Inc
DOW
$21.6B
$13K 0.01%
298
+170
+133% +$8.62K
2021 Q4
3 quarters
LULU icon
240
lululemon athletica
LULU
$11.4B
$13K 0.01%
45
– –
2022 Q1
2 quarters
SCHA icon
241
Schwab U.S Small- Cap ETF
SCHA
$21.4B
$13K 0.01%
680
– –
2021 Q4
3 quarters
TDOC icon
242
Teladoc Health
TDOC
$1.06B
$13K 0.01%
500
– –
2021 Q4
3 quarters
WBA icon
243
DELISTED
Walgreens Boots Alliance
WBA
$13K 0.01%
423
-27
-6% -$1K
2022 Q1
2 quarters
ABMD
244
DELISTED
Abiomed Inc
ABMD
$13K 0.01%
53
– –
2022 Q1
2 quarters
ATVI
245
DELISTED
Activision Blizzard
ATVI
$13K 0.01%
170
+100
+143% +$7.83K
2022 Q1
2 quarters
CAG icon
246
Conagra Brands
CAG
$6.82B
$12K 0.01%
+364
New +$12.5K
2022 Q3
0 quarters
WMT icon
247
Walmart Inc
WMT
$941B
$12K 0.01%
285
-600
-68% -$26.3K
2021 Q4
3 quarters
AZN icon
248
AstraZeneca
AZN
$256B
$11K 0.01%
100
– –
2021 Q4
3 quarters
CARR icon
249
Carrier Global
CARR
$45.7B
$11K 0.01%
300
– –
2021 Q4
3 quarters
KRNT icon
250
Kornit Digital
KRNT
$735M
$11K 0.01%
425
+150
+55% +$4.32K
2022 Q1
2 quarters

Similar funds

Operose Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Operose Advisors held 351 positions worth $152M, up 7.1% from $142M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Operose Advisors deployed $20.9M of net new capital in Q3 2022, opening 49 new positions and adding to 55 existing holdings. Its largest new stake was iShares US Real Estate ETF: 3,725 shares worth $303K.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 87% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard ESG International Stock ETF, an estimated $598K trimmed.

  • Operose Advisors's largest Q3 2022 buy was iShares US Real Estate ETF: 3,725 shares worth $303K.
  • Operose Advisors added most to iShares National Muni Bond ETF in Q3 2022, an estimated $5.51M increase.
  • Operose Advisors's biggest Q3 2022 reduction was Vanguard ESG International Stock ETF, cutting an estimated $598K.
  • Operose Advisors fully exited PS Business Parks, Inc. in Q3 2022, selling an estimated $26K.
  • Operose Advisors's ten largest holdings make up 73% of its $152M portfolio in Q3 2022.
  • Operose Advisors opened 49 new positions and closed 8 in Q3 2022.
  • Operose Advisors's portfolio value rose 7.1% quarter-over-quarter to $152M.

Based on Operose Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.